Eric dEsparbes

CIK 1622268 · Chief Financial Officer · last filed 2024-08-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.57M

Companies

4

Total Filings

35

Lifetime Open-Market Net

-$504.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIORA THERAPEUTICS, INC. (BIOR) Delisted Chief Financial Officer 575,832 $0.22 $126.7K $0 10 2024-08-16
BIORA THERAPEUTICS, INC. (PROG) Delisted Chief Financial Officer 423,171 $0.88 $374.3K $0 9 2022-04-19
INVA SVP and CFO 376,965 $22.74 $8.57M -$504.5K 13 2018-05-22
Innoviva, Inc. (THRX) Delisted SVP and CFO 132,779 $4.06 $539.1K $0 3 2015-11-23

Recent Filings · Page 4 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-02-23 INVA Tax (F) −5,457 -$67.0K EDGAR
2016-01-19 INVA Grant (A) +115,734 $0 EDGAR
2015-11-23 Innoviva, Inc. (THRX) Delisted Tax (F) −7,940 -$70.8K EDGAR
2015-01-09 Innoviva, Inc. (THRX) Delisted Grant (A) +36,972 $0 EDGAR
2014-10-17 Innoviva, Inc. (THRX) Delisted Grant (A) +102,471 $0 EDGAR
Showing 3135 of 35
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.